000			02185 a2200601 4500
005			20250513184358.0
264		0	_c19990811
008			199908s 0 0 eng d
022			_a0923-7534
024	7		_a10.1023/a:1008360406322 _2doi
040			_aNLM _beng _cNLM
100	1		_aHolmes, F A
245	0	0	_aPaclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: phase I results. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cApr 1999
300			_a403-11 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBiomarkers, Tumor _xanalysis
650	0	4	_aBone Neoplasms _xsecondary
650	0	4	_aBreast Neoplasms _xdiagnosis
650	0	4	_aDisease-Free Survival
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHeart Diseases _xchemically induced
650	0	4	_aHumans
650	0	4	_aInfusions, Intravenous
650	0	4	_aLung Neoplasms _xsecondary
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Metastasis
650	0	4	_aPaclitaxel _xadministration & dosage
650	0	4	_aSeverity of Illness Index
650	0	4	_aSoft Tissue Neoplasms _xsecondary
650	0	4	_aSurvival Rate
650	0	4	_aTreatment Outcome
700	1		_aValero, V
700	1		_aWalters, R S
700	1		_aTheriault, R L
700	1		_aBooser, D J
700	1		_aGibbs, H
700	1		_aFraschini, G
700	1		_aBuzdar, A U
700	1		_aWilley, J
700	1		_aFrye, D
700	1		_aAsmar, L
700	1		_aHortobagyi, G N
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 10 _gno. 4 _gp. 403-11
856	4	0	_uhttps://doi.org/10.1023/a:1008360406322 _zAvailable from publisher's website
999			_c10329272 _d10329272